PT2739621T - Cristais do composto 2-acilaminotiazol - Google Patents
Cristais do composto 2-acilaminotiazolInfo
- Publication number
- PT2739621T PT2739621T PT127598332T PT12759833T PT2739621T PT 2739621 T PT2739621 T PT 2739621T PT 127598332 T PT127598332 T PT 127598332T PT 12759833 T PT12759833 T PT 12759833T PT 2739621 T PT2739621 T PT 2739621T
- Authority
- PT
- Portugal
- Prior art keywords
- acylaminotiazole
- composition crystals
- crystals
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011169730A JP2014144916A (ja) | 2011-08-03 | 2011-08-03 | ２−アシルアミノチアゾール化合物の結晶 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2739621T true PT2739621T (pt) | 2017-08-16 |
Family
ID=46875935
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT171766702T PT3246325T (pt) | 2011-08-03 | 2012-08-01 | Cristais do composto 2-acilaminotiazol |
| PT127598332T PT2739621T (pt) | 2011-08-03 | 2012-08-01 | Cristais do composto 2-acilaminotiazol |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT171766702T PT3246325T (pt) | 2011-08-03 | 2012-08-01 | Cristais do composto 2-acilaminotiazol |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP3246325B1 (pt) |
| JP (1) | JP2014144916A (pt) |
| CY (2) | CY1120647T1 (pt) |
| DK (2) | DK3246325T3 (pt) |
| ES (2) | ES2784384T3 (pt) |
| HR (2) | HRP20171214T1 (pt) |
| HU (1) | HUE034270T2 (pt) |
| LT (3) | LT3246325T (pt) |
| NO (1) | NO2020032I1 (pt) |
| PL (2) | PL3246325T3 (pt) |
| PT (2) | PT3246325T (pt) |
| RS (1) | RS60358B1 (pt) |
| SI (2) | SI2739621T1 (pt) |
| SM (1) | SMT202000173T1 (pt) |
| WO (1) | WO2013018362A1 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2764866A1 (en) | 2013-02-07 | 2014-08-13 | IP Gesellschaft für Management mbH | Inhibitors of nedd8-activating enzyme |
| CN106749226B (zh) * | 2017-03-15 | 2019-12-20 | 广东赛拓医药科技有限公司 | 一种avatrombopag马来酸盐晶型C的制备方法 |
| WO2020044364A1 (en) | 2018-08-27 | 2020-03-05 | Mylan Laboratories Limited | Polymorphic forms of avatrombopag maleate |
| CN112022825B (zh) * | 2020-08-24 | 2024-03-22 | 瑞阳制药股份有限公司 | 马来酸阿伐曲泊帕片剂及其制备方法 |
| CN112409350B (zh) * | 2020-11-27 | 2023-12-19 | 上海迪赛诺生物医药有限公司 | 一种马来酸阿伐曲泊帕晶型c的制备方法 |
| CN113185510B (zh) * | 2021-04-12 | 2022-05-13 | 南京海纳医药科技股份有限公司 | 一种阿伐曲泊帕杂质的制备方法 |
| WO2025132929A2 (en) | 2023-12-19 | 2025-06-26 | Synthon B.V | Salts of avatrombopag |
| WO2025133011A1 (en) | 2023-12-21 | 2025-06-26 | Synthon B.V | Formulation comprising form b of avatrombopag maleate |
| EP4660195A1 (en) | 2024-06-05 | 2025-12-10 | Noucor Health S.A. | Crystalline forms of avatrombopag maleate and preparation thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101010905B1 (ko) | 2002-01-18 | 2011-01-25 | 아스텔라스세이야쿠 가부시키가이샤 | 2-아실아미노티아졸 유도체 또는 그 염 |
| JP4317818B2 (ja) | 2002-09-30 | 2009-08-19 | アステラス製薬株式会社 | ２−アシルアミノチアゾール誘導体の新規な塩 |
-
2011
- 2011-08-03 JP JP2011169730A patent/JP2014144916A/ja not_active Withdrawn
-
2012
- 2012-08-01 PT PT171766702T patent/PT3246325T/pt unknown
- 2012-08-01 PL PL17176670T patent/PL3246325T3/pl unknown
- 2012-08-01 SI SI201231023T patent/SI2739621T1/sl unknown
- 2012-08-01 WO PCT/JP2012/004885 patent/WO2013018362A1/en not_active Ceased
- 2012-08-01 HR HRP20171214TT patent/HRP20171214T1/hr unknown
- 2012-08-01 ES ES17176670T patent/ES2784384T3/es active Active
- 2012-08-01 EP EP17176670.2A patent/EP3246325B1/en active Active
- 2012-08-01 HU HUE12759833A patent/HUE034270T2/en unknown
- 2012-08-01 DK DK17176670.2T patent/DK3246325T3/da active
- 2012-08-01 SI SI201231757T patent/SI3246325T1/sl unknown
- 2012-08-01 EP EP12759833.2A patent/EP2739621B1/en active Active
- 2012-08-01 PL PL12759833T patent/PL2739621T3/pl unknown
- 2012-08-01 SM SM20200173T patent/SMT202000173T1/it unknown
- 2012-08-01 LT LTEP17176670.2T patent/LT3246325T/lt unknown
- 2012-08-01 DK DK12759833.2T patent/DK2739621T3/en active
- 2012-08-01 ES ES12759833.2T patent/ES2636749T3/es active Active
- 2012-08-01 LT LTEP12759833.2T patent/LT2739621T/lt unknown
- 2012-08-01 RS RS20200374A patent/RS60358B1/sr unknown
- 2012-08-01 PT PT127598332T patent/PT2739621T/pt unknown
-
2017
- 2017-08-09 CY CY171100854T patent/CY1120647T1/el unknown
-
2020
- 2020-04-03 HR HRP20200546TT patent/HRP20200546T1/hr unknown
- 2020-04-13 CY CY20201100344T patent/CY1122974T1/el unknown
- 2020-08-25 LT LTPA2020526C patent/LTC3246325I2/lt unknown
- 2020-09-14 NO NO2020032C patent/NO2020032I1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3246325B1 (en) | 2020-03-25 |
| DK3246325T3 (da) | 2020-04-20 |
| JP2014144916A (ja) | 2014-08-14 |
| LTC3246325I2 (lt) | 2023-11-10 |
| PT3246325T (pt) | 2020-04-21 |
| HRP20171214T1 (hr) | 2017-10-20 |
| RS60358B1 (sr) | 2020-07-31 |
| CY1122974T1 (el) | 2021-10-29 |
| DK2739621T3 (en) | 2017-09-04 |
| ES2784384T3 (es) | 2020-09-24 |
| LT3246325T (lt) | 2020-05-11 |
| SMT202000173T1 (it) | 2020-05-08 |
| EP2739621B1 (en) | 2017-06-21 |
| NO2020032I1 (no) | 2020-09-14 |
| LTPA2020526I1 (lt) | 2020-09-25 |
| PL3246325T3 (pl) | 2020-07-27 |
| EP2739621A1 (en) | 2014-06-11 |
| LT2739621T (lt) | 2017-09-25 |
| CY1120647T1 (el) | 2019-12-11 |
| WO2013018362A1 (en) | 2013-02-07 |
| HK1246793A1 (en) | 2018-09-14 |
| ES2636749T3 (es) | 2017-10-09 |
| SI2739621T1 (sl) | 2017-10-30 |
| HRP20200546T1 (hr) | 2020-08-07 |
| EP3246325A1 (en) | 2017-11-22 |
| PL2739621T3 (pl) | 2017-12-29 |
| HUE034270T2 (en) | 2018-02-28 |
| SI3246325T1 (sl) | 2020-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT2742151T (lt) | Polimerazės kompozicija | |
| BR112013022112A2 (pt) | composição | |
| BR112013022102A2 (pt) | composição | |
| DK2686017T3 (da) | Oftalmisk sammensætning | |
| BR112014004395A2 (pt) | composição | |
| LT2791160T (lt) | Modifikuotos mrnr sudėtys | |
| EP2772523A4 (en) | THERMOCHROMICALLY REVERSIBLE COMPOSITION | |
| EP2799514A4 (en) | PHOTOCHROME COMPOSITION | |
| EP2677015A4 (en) | ADHESIVE COMPOSITION | |
| EP2675909A4 (en) | GLUCOSYLSTEVIA COMPOSITION | |
| LT2751083T (lt) | Kvinolono junginys | |
| EP2720561A4 (en) | Stevia-COMPOSITION | |
| EP2713762A4 (en) | Stevia-COMPOSITION | |
| EP2787837A4 (en) | COMMONLY DECOMPOSED STABILIZER COMPOSITION | |
| EP2796523A4 (en) | ADHESIVE COMPOSITION | |
| HUE053745T2 (hu) | Helyettesített 5-fluor-1H-pirazolopiridin kristályos formában | |
| BR112014012016A2 (pt) | compostos | |
| DE102011100082A8 (de) | Traygreifvorrichtung | |
| PL2672840T3 (pl) | Kompozycja stewii | |
| CO6910197A2 (es) | Compuestos novedosos | |
| LTC3246325I2 (lt) | 2-acilaminotiazolo junginio kristalai | |
| BR112014000879A2 (pt) | deflegmador | |
| BR112013033808A2 (pt) | composição | |
| DK2706977T3 (da) | Dispergeringsmidler med biobaserede forbindelser | |
| CO6960543A2 (es) | 2-tiopirimidinonas |